Hyperprogressive disease in lung metastases without target lesion progression after durvalumab consolidation therapy: A case report

Hyperprogressive disease (HPD) is a novel progressive pattern that occurs after immune checkpoint inhibitor (ICI) administration. Here, a 74‐year‐old woman who had undergone right lower lobectomy for lung cancer received curative chemoradiotherapy followed by consolidation therapy with durvalumab fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Masuda, Kosuke, Nagai, Yoshiaki, Amari, Hikari, Tahara, Hiroki, Maeda, Yuki, Shiihara, Jun, Ohta, Hiromitsu, Hiruta, Masahiro, Yamaguchi, Yasuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626253/
https://www.ncbi.nlm.nih.gov/pubmed/37699791
http://dx.doi.org/10.1111/1759-7714.15104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626253/
https://www.ncbi.nlm.nih.gov/pubmed/37699791
http://dx.doi.org/10.1111/1759-7714.15104

Ejemplares similares